US$ 24.91
otc glp-1 agonists How medications are transforming diabetes and weight loss treatment GLP-1's: What They Are and
Description
Foo, H., Crabtree, K., Thrasher, A

JAMA Pediatr 178 , 1307-1315 (2024)

Pancreatitis: Though rare, there is a potential risk of pancreatitis, a serious condition involving inflammation of the pancreas

Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials

But semaglutide is approved and available now, while retatrutide is still in Phase 3

But they come with risks, research gaps, and liability concerns
